BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 21, 2016
View Archived Issues
[11C]GSK-1482160: a PET radiotracer for imaging P2X7 receptors in neuroinflammation
Read More
Cell Medica and Baylor collaborate on next-generation cellular immunotherapies
Read More
Cancer Moonshot 2020 program forms the Melanoma and Sarcoma Working Group
Read More
Novartis initiates phase I/Ib study of LSZ-102 in ER-positive breast cancer
Read More
OxiGENE changes company name to Mateon Therapeutics
Read More
New rexinoid shows promise for the treatment of obesity and diabetes
Read More
Novira Therapeutics patents anti-HBV compounds
Read More
Array BioPharma and Celgene report JAK inhibitors
Read More
Intra-Cellular Therapies presents PDE2A inhibitors
Read More
Inovio Pharmaceuticals cleared to begin first phase I trial of Zika vaccine
Read More
Nivolumab evaluated for metastatic uterine leiomyosarcoma, colorectal cancer and ovarian cancer
Read More
Ipafricept plus carboplatin and paclitaxel well tolerated in phase Ib trial
Read More
FDA clears Sangamo BioSciences' IND for SB-913
Read More
EUROSTARS grant supports development of APO-010 for multiple myeloma
Read More
Afstyla available in U.S. for hemophilia A
Read More
Mitsubishi Tanabe Pharma submits NDA for edaravone for ALS
Read More
ApeX Therapeutics files IND for phase I trial of APX-3330 for pancreatic ductal adenocarcinoma
Read More
First-in-human results for the novel oral RAF inhibitor HM-95573
Read More
Takeda begins phase IIb trial for norovirus vaccine
Read More
New phase I trial studies UCART-19 in pediatric patients with B-ALL
Read More
Enanta starts phase I trial pan-genotypic cyclophilin inhibitor for HCV
Read More
FDA approves Rayaldee for secondary hyperparathyroidism in CKD
Read More
FDA approves use of Procleix Zika virus blood screening assay under IND study protocol
Read More
Inhibition of TGF-beta signaling to treat myelofibrosis
Read More